Inventor
MAHER CAROLINE
US3 patents
Patents
3 patentsUS10007766B2Jun 26, 2018
Predictive test for melanoma patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC9 citations81
US10950348B2Mar 16, 2021
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC2 citations70
US12230398B2Feb 18, 2025
Predictive test for patient benefit from antibody drug blocking ligand activation of the T-cell programmed cell death 1 (PD-1) checkpoint protein and classifier development methods
BIODESIX INC0 citations56